At close: December 20 at 4:00:00 PM EST
After hours: December 20 at 7:59:18 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
81.0000
81.0000
1,030.0000
1,144.0000
--
Operating Expense
45,040.0000
52,001.0000
35,134.0000
26,108.0000
22,393.0000
Operating Income
-44,959.0000
-51,920.0000
-34,104.0000
-24,964.0000
-22,393.0000
Net Non Operating Interest Income Expense
4,044.0000
3,102.0000
1,087.0000
190.0000
178.0000
Pretax Income
-40,915.0000
-48,818.0000
-33,017.0000
-24,774.0000
-22,215.0000
Net Income Common Stockholders
-40,915.0000
-48,818.0000
-33,017.0000
-24,774.0000
-22,216.0000
Diluted NI Available to Com Stockholders
-40,915.0000
-48,818.0000
-33,017.0000
-24,774.0000
-22,216.0000
Basic EPS
-1.39
-1.83
-1.37
-1.20
-1.83
Diluted EPS
-1.39
-1.83
-1.37
-1.20
-1.83
Basic Average Shares
29,126.0720
26,604.0450
24,141.5450
20,568.3730
12,134.2590
Diluted Average Shares
29,126.0720
26,604.0450
24,141.5450
20,568.3730
12,134.2590
Total Operating Income as Reported
-44,959.0000
-51,920.0000
-34,104.0000
-24,964.0000
-22,393.0000
Total Expenses
45,040.0000
52,001.0000
35,134.0000
26,108.0000
22,393.0000
Net Income from Continuing & Discontinued Operation
-40,915.0000
-48,818.0000
-33,017.0000
-24,774.0000
-22,215.0000
Normalized Income
-40,915.0000
-48,818.0000
-33,017.0000
-24,774.0000
-22,215.0000
Interest Income
4,044.0000
3,102.0000
1,087.0000
190.0000
178.0000
Net Interest Income
4,044.0000
3,102.0000
1,087.0000
190.0000
178.0000
EBIT
-44,959.0000
-51,920.0000
-34,104.0000
-24,964.0000
-22,393.0000
EBITDA
-44,153.0000
-51,130.0000
-33,405.0000
-24,440.0000
-21,946.0000
Reconciled Depreciation
806.0000
790.0000
699.0000
524.0000
447.0000
Net Income from Continuing Operation Net Minority Interest
-40,915.0000
-48,818.0000
-33,017.0000
-24,774.0000
-22,215.0000
Normalized EBITDA
-44,153.0000
-51,130.0000
-33,405.0000
-24,440.0000
-21,946.0000
12/31/2020 - 12/27/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACET Adicet Bio, Inc.
0.9100
+5.78%
SLS SELLAS Life Sciences Group, Inc.
0.8880
-1.11%
ENTX Entera Bio Ltd.
2.1000
-3.23%
AFMD Affimed N.V.
1.1900
+0.85%
AGEN Agenus Inc.
2.8300
+2.54%
MREO Mereo BioPharma Group plc
3.3500
+1.82%
ALLK Allakos Inc.
1.2000
-6.98%
RVPH Reviva Pharmaceuticals Holdings, Inc.
1.3400
-10.67%
AXSM Axsome Therapeutics, Inc.
90.73
+1.10%
ATYR aTyr Pharma, Inc.
3.3500
+6.35%